Search Results
You are looking at 1 - 8 of 8 items for
- Author: H. Yamada x
- Refine by access: All content x
Search for other papers by A. Sakurai in
Google Scholar
PubMed
Search for other papers by K. Ichikawa in
Google Scholar
PubMed
Search for other papers by K. Hashizume in
Google Scholar
PubMed
Search for other papers by T. Miyamoto in
Google Scholar
PubMed
Search for other papers by K. Yamauchi in
Google Scholar
PubMed
Search for other papers by H. Ohtsuka in
Google Scholar
PubMed
Search for other papers by Y. Nishii in
Google Scholar
PubMed
Search for other papers by T. Yamada in
Google Scholar
PubMed
ABSTRACT
The effects of histone subfractions on rat liver thyroid hormone receptor–DNA interaction were examined using an in-vitro DNA-cellulose binding assay. H1 histones bound to DNA showed reversible and potent inhibition of receptor–DNA binding without affecting receptor–hormone binding. Poly-lysine, bovine serum albumin, ovalbumin and cytochrome c did not alter receptor–DNA binding. H1 histone subfractions (calf thymus lysine-rich histone (CTL)-1, CTL-2 and CTL-3) showed potent inhibition of receptor–DNA binding indistinguishable from each other. The quantity of H1 histone subfractions bound to DNA was the same. Although each subfraction has different functional properties, inhibition of receptor–DNA binding was a common feature of all the H1 histone subfractions, which is important for the non-random distribution of the receptor in chromatin.
Binding of the receptor to core histones was investigated; it was found to bind to core histones more potently than to other proteins (H1 histone, ovalbumin and cytochrome c). Among core histone subfractions, H4 histone bound to the receptor most potently and is the candidate to be one of the acceptor sites of the receptor in chromatin.
Journal of Endocrinology (1989) 121, 337–341
Search for other papers by K. Ichikawa in
Google Scholar
PubMed
Search for other papers by K. Hashizume in
Google Scholar
PubMed
Search for other papers by T. Miyamoto in
Google Scholar
PubMed
Search for other papers by Y. Nishii in
Google Scholar
PubMed
Search for other papers by K. Yamauchi in
Google Scholar
PubMed
Search for other papers by H. Ohtsuka in
Google Scholar
PubMed
Search for other papers by T. Yamada in
Google Scholar
PubMed
ABSTRACT
An aqueous two-phase partitioning study of partially purified nuclear thyroid hormone receptor from rat liver was performed. Stability of 3,5,3′-tri-iodo-l-thyronine (T3)–receptor complex and T3-binding activity in the presence of dextran or polyethylene glycol were assessed in order to determine the amount of occupied or unoccupied receptors in each phase. Partition coefficients were calculated as the ratio of receptor concentration in the upper polyethylene glycol-rich phase H2O and that in the lower dextranrich phase H2O. The partition coefficient was a sensitive function of the salt at pH above 6·1 and below 5·1. The salt had no effect on the partition coefficient at pH around 5·6. These results suggest that the isoelectric point of the thyroid hormone receptor is about 5·6, confirming previous determinations using isoelectric focusing. The partition coefficient of the receptor decreased upon T3 binding, regardless of the salt composition. In contrast, the partition coefficient of thyroxine-binding globulin increased upon T3 binding. Free T3 preferentially partitioned into the upper polyethylene glycol-rich phase and gave a partition coefficient higher than 1·0. These results strongly suggest that the decrease in the partition coefficient of the receptor upon hormone binding reflects conformational changes or changes in electrostatic properties of the receptor upon hormone binding. Such an alteration may be involved in biological activation of the receptor upon hormone binding.
J. Endocr. (1988) 119, 431–437
Search for other papers by T Ishizuka in
Google Scholar
PubMed
Search for other papers by A Miura in
Google Scholar
PubMed
Search for other papers by K Kajita in
Google Scholar
PubMed
Search for other papers by K Yamada in
Google Scholar
PubMed
Search for other papers by H Wada in
Google Scholar
PubMed
Search for other papers by S Itaya in
Google Scholar
PubMed
Search for other papers by Y Kanoh in
Google Scholar
PubMed
Search for other papers by M Ishizawa in
Google Scholar
PubMed
Search for other papers by M Kimura in
Google Scholar
PubMed
Search for other papers by K Yasuda in
Google Scholar
PubMed
The Otsuka Long-Evans Tokushima fatty (OLETF) rat is a new spontaneous non-insulin-dependent diabetes mellitus (NIDDM) model rat strain developed in Tokushima, Japan. After 18 weeks of age, decreases of 45% and 40% respectively in insulin- and phorbol ester-stimulated [3H]2-deoxyglucose (DOG) uptake were observed, compared with those in Long-Evans Tokushima (LETO) rats (control). Insulin-specific binding and 95 kDa autophosphorylation of insulin receptor in OLETF rats were not different from those in LETO rats. Insulin-induced diacylglycerol (DG) production and Mono Q column-purified protein kinase C (PKC) translocation in adipocytes of OLETF rats were decreased compared with those of LETO rats. Insulin-induced PKC beta translocation from cytosol to membrane was also decreased in adipocytes of OLETF rats. Increases of the PKC beta I, beta II, epsilon and zeta isoforms in membranes of OLETF rats were markedly smaller than those of LETO rats. Analysis of mRNA levels of PKC isoforms in adipocytes of OLETF rats showed decreases of basal level and insulin-induced delayed responses of PKC beta I, beta II, epsilon and zeta mRNA in OLETF rats. On the other hand, insulin- or phorbol ester-induced phosphatidylinositol 3-kinase (PI 3-kinase) activation was decreased in adipocytes of OLETF rats compared with those of LETO rats. These results suggest that insulin resistance in OLETF rats, a spontaneous NIDDM model rat, may be associated with deterioration of insulin-induced DG-PKC signaling and subsequent decrease in PI 3-kinase activation.
Search for other papers by K. Tamura in
Google Scholar
PubMed
Search for other papers by M. Kobayashi in
Google Scholar
PubMed
Search for other papers by S. Suzuki in
Google Scholar
PubMed
Search for other papers by Y. Ishii in
Google Scholar
PubMed
Search for other papers by S. Koyama in
Google Scholar
PubMed
Search for other papers by H. Yamada in
Google Scholar
PubMed
Search for other papers by K. Hashimoto in
Google Scholar
PubMed
Search for other papers by M. Niwa in
Google Scholar
PubMed
Search for other papers by F. Shibayama in
Google Scholar
PubMed
ABSTRACT
Monoclonal antibodies (McAb) and polyclonal antibodies (PcAb) against human insulin-like growth factor-I (somatomedin C; hIGF-I) were produced. Using these two antibodies, an enzyme-linked immunosorbent assay (ELISA) system for hIGF-I was established. The ELISA system was able to detect hIGF-I at a range of 1–25 μg/l, compared with the range of 1–50 μg/l detected by radioimmunoassay (RIA). Human IGF-II and human insulin could not be recognized in this system. The plasma concentrations of IGF-I found using the ELISA agreed well with those found using RIA after conventional Sep-Pak C18 cartridge pretreatment. Epitopes of hIGF-I to McAb and PcAb were investigated by enzymatic digestion of hIGF-I followed by comparing the affinity of the antibodies to the peptides obtained proteolytically. The epitope to McAb was found to be a peptide containing Leu10-Val11-Asp12 (epitope 2). Five epitopes to PcAb containing the following key fragments were identified: a conformational structure formed by the disulphide bonds between Cys6 and Cys48, and between Cys47 and Cys52 (epitope 1), Leu10-Val11-Asp12 (epitope 2), Val17-Cys18-Gly19-Asp20 (epitope 3), Arg21-Gly22-Phe23-Tyr24 (epitope 4) and Lys68-Ser69-Ala70 (epitope 5). Of these, the peptide containing epitope 5 showed the highest affinity to PcAb. The results indicated that our ELISA system combined recognition by epitope 2 of McAb and recognition by epitope 5 of PcAb to obtain its good specificity.
Journal of Endocrinology (1990) 125, 327–335
Search for other papers by T Usui in
Google Scholar
PubMed
Search for other papers by Y Ikeda in
Google Scholar
PubMed
Search for other papers by T Tagami in
Google Scholar
PubMed
Search for other papers by K Matsuda in
Google Scholar
PubMed
Search for other papers by K Moriyama in
Google Scholar
PubMed
Search for other papers by K Yamada in
Google Scholar
PubMed
Search for other papers by H Kuzuya in
Google Scholar
PubMed
Search for other papers by S Kohno in
Google Scholar
PubMed
Search for other papers by A Shimatsu in
Google Scholar
PubMed
Some plant compounds or herb mixtures are popular alternatives to conventional therapies and contain organic compounds that bind to some nuclear receptors, such as the estrogen receptor (ER), to exert various biological effects. We studied the effect of various herbal extracts on ERalpha and ERbeta isoforms. One herbal extract, Rhei rhizoma (rhubarb), acts as an agonist to both ERalpha and ERbeta. The phytochemical lindleyin, a major component of rhubarb, might contribute to this estrogenic activity through ERalpha and ERbeta. 4-Hydroxytamoxifen, an ER antagonist, completely reversed the estrogenic activity of lindleyin. Lindleyin binds to ERalpha in vitro, as demonstrated using a fluorescent polarization assay. The in vivo effect of rhubarb extract was studied using a vitellogenin assay system in the freshwater fish, Japanese medaka (Oryzias latipes). There were marked increases in serum vitellogenin levels in male medaka exposed to rhubarb extract. We conclude that lindleyin, a component of some herbal medicines, is a novel phytoestrogen and might trigger many of the biological responses evoked by the physiological estrogens.
Search for other papers by S Yamada in
Google Scholar
PubMed
Search for other papers by M Komatsu in
Google Scholar
PubMed
Search for other papers by T Aizawa in
Google Scholar
PubMed
Search for other papers by Y Sato in
Google Scholar
PubMed
Search for other papers by H Yajima in
Google Scholar
PubMed
Search for other papers by T Yada in
Google Scholar
PubMed
Search for other papers by S Hashiguchi in
Google Scholar
PubMed
Search for other papers by K Yamauchi in
Google Scholar
PubMed
Search for other papers by K Hashizume in
Google Scholar
PubMed
When isolated rat pancreatic islets are treated with 16.7 mM glucose, a time-dependent potentiation (TDP) of insulin release occurs that can be detected by subsequent treatment with 50 mM KCl. It has been thought that TDP by glucose is a Ca2+-dependent phenomenon and only occurs when exposure to glucose is carried out in the presence of Ca2+. In contrast to this, we now demonstrate TDP under stringent Ca2+-free conditions (Ca2+-free buffer containing 1 mM EGTA). In fact, under these Ca2+-free conditions glucose caused an even stronger TDP than in the presence of Ca2+. TDP induced by glucose in the absence of extracellular Ca2+ was unaffected by inhibitors of protein kinase C (PKC). However, cerulenin or tunicamycin, two inhibitors of protein acylation, eradicated TDP without affecting glucose metabolism. The TDP by glucose was not associated with an increase in the cytosolic free Ca2+ concentration ([Ca2+]i) during subsequent treatment with high K+. Exposure of islets to forskolin under Ca(2+)-free conditions did not cause TDP despite a large increase in the cellular cAMP levels. In conclusion, glucose alone induces TDP under stringent Ca2+-free conditions when [Ca2+]i was significantly lowered. Protein acylation is implicated in the underlying mechanism of TDP.
Search for other papers by S Otabe in
Google Scholar
PubMed
Search for other papers by N Wada in
Google Scholar
PubMed
Search for other papers by T Hashinaga in
Google Scholar
PubMed
Search for other papers by X Yuan in
Google Scholar
PubMed
Search for other papers by I Shimokawa in
Google Scholar
PubMed
Search for other papers by T Fukutani in
Google Scholar
PubMed
Search for other papers by K Tanaka in
Google Scholar
PubMed
Search for other papers by T Ohki in
Google Scholar
PubMed
Search for other papers by S Kakino in
Google Scholar
PubMed
Search for other papers by Y Kurita in
Google Scholar
PubMed
Search for other papers by H Nakayama in
Google Scholar
PubMed
Search for other papers by Y Tajiri in
Google Scholar
PubMed
Search for other papers by K Yamada in
Google Scholar
PubMed
We previously reported that transgenic (Tg) expression of adiponectin significantly prolonged the lifespan of normal mice. The aim of this study was to elucidate the mechanism involved in the longevity effects of adiponectin using KK/Ta mice, a murine model of metabolic syndrome. We established a Tg line of KK/Ta (Tg-KK/Ta) mice expressing human adiponectin in the liver, and assessed their lifespan. The cause of death was determined by macroscopic and microscopic examinations immediately after death. The expressions of SIRT1, C-reactive protein (CRP), inflammatory cytokines, AMPK, and AKT were measured by quantitative real-time PCR, ELISAs, and/or western blotting. KK/Ta mice had lower serum adiponectin levels and shorter lifespan (57.6±13.9 vs 106.5±18.3 weeks, P<0.0001) than C57BL/6N mice. Tg adiponectin expression significantly extended the lifespan of KK/Ta mice (73.6±16.6 weeks, P<0.001) without affecting body weight, daily food consumption, or plasma glucose levels. Neoplasms were observed in only three of 22 KK/Ta mice that died spontaneously because of tumors. Atherosclerotic lesions were not detected in any mice. SIRT1 levels were not significantly different between KK/Ta and Tg-KK/Ta mice. Gene expressions of Crp, Tnf α, Il6, and Nf κ b were increased in KK/Ta mice, but they were significantly attenuated in Tg-KK/Ta mice. Phosphorylated AMPK levels were increased and phosphorylated AKT levels were decreased in Tg-KK/Ta mice. The anti-inflammatory effects of adiponectin, achieved by inhibiting the AKT signaling pathway, may explain how adiponectin slows the accelerated aging process associated with the metabolic syndrome.
Search for other papers by T Aizawa in
Google Scholar
PubMed
Search for other papers by T Kaneko in
Google Scholar
PubMed
Search for other papers by H Yajima in
Google Scholar
PubMed
Search for other papers by S Yamada in
Google Scholar
PubMed
Search for other papers by Y Sato in
Google Scholar
PubMed
Search for other papers by Y Kanda in
Google Scholar
PubMed
Search for other papers by S Kanda in
Google Scholar
PubMed
Search for other papers by M Noda in
Google Scholar
PubMed
Search for other papers by T Kadowaki in
Google Scholar
PubMed
Search for other papers by M Nagai in
Google Scholar
PubMed
Search for other papers by K Yamauchi in
Google Scholar
PubMed
Search for other papers by M Komatsu in
Google Scholar
PubMed
Search for other papers by K Hashizume in
Google Scholar
PubMed
Oscillation of insulin release by the pancreatic islets was evaluated under stringent Ca(2+)-free conditions for the first time. Isolated single rat islets were exposed to 16.7 mM glucose in the presence of 1.9 mM Ca(2+), or under the stringent Ca(2+)-free conditions (Ca(2+) omission with 1 mM EGTA, 6 microM forskolin and 100 nM phorbol 12-myristate 13-acetate). Fifteen minutes after the initiation of glucose stimulation, effluent was collected at a 6-s interval, insulin was determined in duplicate by a highly sensitive insulin radioimmunoassay, and oscillation and pulsatility of release statistically analyzed. Significant oscillation of insulin release was observed in all islets irrespective of presence and absence of Ca(2+). Significant pulsatility of release was detected in 7 of 11 islets in the presence of Ca(2+) and three of six isl! ets in the absence of Ca(2+). In conclusion, high glucose elicits oscillatory insulin release both in the presence and absence of extracellular Ca(2+).
